Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children
The results revealed the immuno-persistence after the fourth and fifth doses of IPV and highlighted the importance of completing immunization series to ensure high vaccination coverage, particularly among children in the developing countries affected by the COVID-19 pandemic.
Authors
- Tiffany H.K. Lo
- Kathy Leung (ORCID: https://orcid.org/0000-0003-4777-388X)
- Tommy Tsan‐Yuk Lam (ORCID: https://orcid.org/0000-0002-9769-1527)
- Juan C. Vargas-Zambrano (ORCID: https://orcid.org/0000-0002-5609-7046)
- Chrissy Wing Kwan Pang (ORCID: https://orcid.org/0009-0005-5717-3695)
- Céline Petit (ORCID: https://orcid.org/0000-0002-9829-7011)
- Eric H. Y. Lau (ORCID: https://orcid.org/0000-0002-6688-9637)
- Joseph T. Wu (ORCID: https://orcid.org/0000-0002-3155-5987)
Institutions
- Department of Health (CN)
- Hong Kong Science and Technology Parks Corporation (HK)
- Sanofi (France) (FR)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Clinical Microbiology and Infection
- Published
- 2024-10-12
- DOI
- https://doi.org/10.1016/j.cmi.2024.10.007
- Citations
- 2
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Bill and Melinda Gates Foundation
- Sanofi
- Innovation and Technology Commission
- Sanofi Pasteur
- Health and Medical Research Fund